Navigation Links
From Encision Inc.: New Medicare Penalties to Include Laparoscopic Complications
Date:8/14/2013

BOULDER, Colo., Aug. 14, 2013 /PRNewswire/ -- Encision Inc. (ECIA:PK).  According to the Centers for Medicare and Medicaid Services ("CMS"), hospitals must now focus on reducing laparoscopic surgical complications, including lacerations and accidental punctures, or face penalties. Half of all unintended punctures and lacerations during laparoscopic monopolar surgery are caused by stray electrosurgical energy and half are caused by mechanical perforation.  Stray energy burns alone have accounted for more than 16,500 preventable patient complications and 4,000 preventable patient deaths over a ten year period in the U.S. alone.[1]

CMS issued its final ruling on August 2, 2013.  The ruling is aimed at reducing selected complications that are high cost, high frequency and preventable.  The program referred to as the Hospital-Acquired Condition ("HAC") Reduction Program, identifies occurrences of complications at hospitals and forms the basis for comparing complication rates. Under the new rule, CMS will penalize 1% of all Medicare Inpatient Prospective Payment System revenue for hospitals performing in the worst-performing quartile for these new HAC quality measures, beginning October 1, 2014.

As additional evidence that laparoscopic complications are facing more scrutiny, the National Quality Forum ("NQF") has recently highlighted errant electrosurgical energy in its definition of accidental lacerations and punctures as it relates to the new Medicare HAC reduction program.

"We applaud both CMS' and NQF's efforts to recognize laparoscopic complications as a major issue," said Fred Perner, Encision's President and CEO.  "Consistent with the goal to reduce preventable laparoscopic complications, Encision's AEM® technology eliminates one of the significant contributors to complications, stray monopolar energy.  We are proud to contribute to the collective objective of enhancing patient safety by improving the quality and safety of laparoscopic surgery."

About Encision 

Encision Inc. designs, develops, manufactures and markets innovative surgical devices that allow surgeons to optimize technique and patient safety during a broad range of laparoscopic surgical procedures. Based in Boulder, Colorado, the Company pioneered the development of patented AEM® Technology, the only commercially available products that eliminate stray energy burns to patients during laparoscopic monopolar surgery.  For more information, visit our website at www.encision.com

[1] References available upon request.

In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Company notes that statements in this press release and elsewhere that look forward in time, which include everything other than historical information, involve risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could cause the Company's actual results to differ materially include, among others, its ability to increase net sales through the Company's distribution channels, its ability to compete successfully against other manufacturers of surgical instruments, insufficient quantity of new account conversions, insufficient cash to fund operations, delay in developing new products and receiving FDA approval for such new products and other factors discussed in the Company's filings with the Securities and Exchange Commission. Readers are encouraged to review the risk factors and other disclosures appearing in the Company's Annual Report on Form 10-K for the year ended March 31, 2013 and subsequent filings with the Securities and Exchange Commission. We do not undertake any obligation to update publicly any forward-looking statements, whether as a result of the receipt of new information, future events, or otherwise.

CONTACT: Mala Ray, Encision Inc., 303-444-2600, mray@encision.com


'/>"/>
SOURCE Encision Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Encision Names Patrick Pace, M.D. Chairman of the Board
2. Encision Reports First Quarter Fiscal Year 2014 Results
3. Encision to Release First Quarter 2013 Results on July 31, 2013
4. Encision Reports Fourth Quarter and Fiscal Year 2013 Results
5. Encision Inc. and Virtual Ports Ltd. Announce Exclusive Distribution Agreement for Laparoscopic Surgery Devices
6. Encision Reports 10% Product Revenue Increase in Third Quarter of Fiscal Year 2013 Results
7. Encision Reports Second Quarter of Fiscal Year 2013 Results
8. Encision Reports First Quarter of Fiscal Year 2013 Results
9. Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure
10. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
11. Bio-AMD, Inc.: Medical Device Operational Update, Commercial Discussions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Ill. and INDIANAPOLIS , ... students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is ... 2016 scholarship winners, announced today online at www.diabetesscholars.org ... let type 1 diabetes stand in the way of ... has supported the Foundation,s scholarship program since 2012, and ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement ... Vice President of North American Capital Sales at HTG Molecular . ... in the commercialization of the HTG EdgeSeq system and associated reagents in North America. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, ... stem (iPS) cells and other difficult to transfect cells, announces its launch of ... PluriQ™ G9™ Gene Editing System is a complete system for culturing and ...
Breaking Medicine News(10 mins):